NCT00532246已完成4 期
A Study of Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene HCl or Placebo
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 147
- 试验地点
- 1
- 主要终点
- Test the hypothesis that in postmenopausal women with osteoporosis who took lipid lowering meds for more than 6 months > 80% compliant with study drug during CORE trial, mean carotid IMT will be lower in patients treated with raloxifene than placebo
研究概览
简要总结
The purpose of this study is to measure carotid artery IMT at a single visit in a subset of women previously enrolled in the CORE (H3S-MC-GGJY) trial
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 55 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Patients must have completed the Eli Lilly and Company clinical trial CORE (H3S-MC-GGJY) inclusive of visit 5, in one of the 9 participating study sites in California.
- •Patients must have been dispensed study drug in the CORE trial (H3S-MC-GGJY).
排除标准
- •Have received treatment within the last 30 days with a drug that has not received regulatory approval for any indication at the time of study entry
- •Have previously withdrawn from this exploratory study or any other study investigating raloxifene
- •Are employed by Eli Lilly and Company (that is, employees, temporary contract workers, or designees responsible for the conduct the study). Immediate family of Eli Lilly and Company employees may participate in Lilly-sponsored clinical trials, but are not permitted to participate at an Eli Lilly and Company facility. Immediate family is defined as a spouse, parent, child, or sibling, whether biological or legally adopted
- •Are investigator site personnel directly affiliated with the study, or are immediate family of investigator site personnel directly affiliated with the study. Immediate family is defined as a spouse, parent, child, or sibling, whether biological or legally adopted
研究组 & 干预措施
A
Experimental
raloxifene
干预措施: raloxifene (Drug)
B
Placebo Comparator
placebo
干预措施: Placebo (Drug)
结局指标
主要结局
Test the hypothesis that in postmenopausal women with osteoporosis who took lipid lowering meds for more than 6 months > 80% compliant with study drug during CORE trial, mean carotid IMT will be lower in patients treated with raloxifene than placebo
次要结局
- To test the hypothesis that, in postmenopausal women with osteoporosis, mean carotid IMT will be significantly lower in patients treated with raloxifene as compared to mean carotid IMT in patients treated with placebo in the following:
- All enrolled patients who have not been exposed to lipid lowering medication for more than 6 months while in the CORE trial, regardless of study drug compliance.
- All enrolled patients, regardless of lipid lowering drug exposure or compliance with study drug while in CORE
- All enrolled patients who were at least 80% compliant with study drug while in CORE, regardless of use of lipid lowering therapy
研究者
研究点 (1)
Loading locations...
相似试验
撤回
不适用
Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid SurgeryMultinodular GoiterGraves DiseaseEuthyroid GoiterBasedow DiseaseThyroid CancerHyperthyroidismPlummer DiseaseNCT05774535Istituto Auxologico Italiano180
已完成
不适用
CIMT and Plaque Assessment Findings in Subjects Undergoing Stress Echocardiography For Risk StratificationCardiovascular Risk StratificationCarotid Intima-media Thickness (CIMT)Stress Echocardiography (SE)NCT02245048Mayo Clinic73
Unknown
不适用
RF Based QIMT & QAS Study on Chinese AdultsHealthyAdultsCarotid Intima-media ThicknessVascular StiffnessChineseNCT04881292Tang-Du Hospital3,500
已完成
不适用
A Study on Intima Media Thickness (IMT) in Middle-aged SubjectsAtherosclerosisNCT00784264AstraZeneca200
已完成
不适用
Predictive value of carotid intima media thickness for cardiovascular disease in type 2 diabetic patientstype 2 diabetic patientsJPRN-UMIN000009039Juntendo University Graduate School of Medicine1,500